Pharmaceutical Packaging Market

Pharmaceutical Packaging Market by Type (Plastic Bottles, Blister Packs, Labels & Accessories, Caps & Closures, Pre-filled Syringes, Vials, Ampoules), Raw Material, Drug Delivery Mode (Oral Drugs, Injectables, IV Drugs), Region - Global Forecast to 2024

Report Code: CH 3482 Jul, 2019, by marketsandmarkets.com

[162 Pages Report] MarketsandMarkets forecasts the pharmaceutical packaging market is projected to grow from USD 83.6 billion in 2019 to USD 111.9 billion by 2024, at a CAGR of 6.0%. The increasing demand for pharmaceuticals owing to increase in healthcare coverage, growing aging population, and an increase in non-communicable disease in pharmerging economies are the major drivers for the pharmaceutical packaging market. The objective of the report is to define, describe, and forecast the pharmaceutical packaging market size based on type, raw material, drug delivery mode, product type, and region

Pharmaceutical Packaging Market

By type, pre-filled syringes segment is expected to be the fastest-growing type for pharmaceutical packaging during the forecast period

Pre-filled syringes are a replacement for traditional vials and syringes. The prefilled syringes aids to reduce wastage, provide patient compliance by offering self-administered metered dosage. The presence of the properties mentioned above, easy handling, and reduction in breakage failure provided by these syringes, boosts demand for pre-filled syringes.  The rise in aging population, increase in non-communicable disease such as diabetes, are driving the demand for pre-filled syringes.

By raw material, plastic & polymers is expected to be the largest raw material used in pharmaceutical packaging during the forecast period

Pharmaceutical Packaging Market

Plastic & polymers are the major raw material type used for pharmaceutical packaging. Variety of plastics such as HDPE, LDPE, PET, and others are used for pharmaceutical packaging. These are cost-effective raw material with excellent shatter resistance hence reduces loss due to breakage. Plastic can be easily formed in the required shapes such as vials, bottles, syringes, and others. Also, it can be combined with metals such as aluminum to form laminations for flexible packaging. Presence of these properties acts as the major driver for the use of plastic material in pharmaceutical packaging.

By drug delivery mode, oral drug delivery mode is expected to be the largest segment, in the pharmaceutical packaging market during the forecast period.

Oral drug delivery is projected to be the largest drug delivery mode during the forecast period. The growth of this segment can be attributed to patient convenience, flexibility in designing dosage, and cost-effective production.

Pharmaceutical Packaging Market

North America is projected to be the largest market during the forecast period.

North America is projected to be the largest pharmaceutical packaging market during the forecast period. This growth is attributed primarily to the new drug developments, technological advancements such as nanomedicines and biologics in the region. Also, the improved healthcare coverage, alterations in business models such as third party partnership and externalized R&D in the pharmaceutical industry is expected to boost the demand for pharmaceutical packaging. Moreover, growth in chronic disease owing to the rising percentage of the aging population is also responsible for the high growth of this region in the pharmaceutical packaging market. 

Market Dynamics

Driver: Growing pharmaceutical industry in emerging economies

The pharmaceutical industry is growing at a rapid pace in emerging economies. Advanced manufacturing processes, technological innovations, and increased integration of companies have resulted in rapid growth of the industry. This growth of the pharmaceutical industry is driving the pharmaceutical packaging market. The growth is expected to be the highest in emerging economies such as Brazil, Russia, India, and China.  Increasing income levels and growing awareness about the advantages of good healthcare systems and healthier lifestyles is supporting the growth of the market in these countries. Large population and demographics factors such as growing young population and higher life expectancy are also the key drivers of this growth. According to the World Bank, healthcare expenditure of Brazil, China, and India was around 11.8%, 5.0%, and 3.7% of the GDP in 2016, which was a substantial increase from 2015. 
As the developed markets (US, UK, Germany, France, and Italy) become saturated, pharmaceutical companies are aligning their growth strategies largely on the rapidly expanding emerging markets, especially the BRIC countries. The market expansion, increasing aging population, clinical and technological advances, and rising expenses in public healthcare systems is providing opportunity for pharmaceutical companies to expand in this region. This is, subsequently, propelling the pharmaceutical packaging market.

Restraint: Increasing overall packaging costs owing to dynamic regulatory policies

Pharmaceutical packaging continues to increase in demand with the growth of the pharmaceutical Industry. However, its growth is likely to be hampered by the high cost of manufacturing. Owing to the need for longer shelf-life and to comply to stringent safety standards set by regulators such as the US Food and Drug Administration (FDA), European Medicines Agency (EMA), and Heads of Medicines Agencies (HMA),  packaging suppliers have to put more effort  to streamline their manufacturing process and produce error-free packaging products. These stakeholders have to add value, adhere to rules, and ensure regulatory compliance. The type and design of packaging material are also influenced by market conditions and strictly regulated by a number of regulatory policies.
Pharmaceutical packaging is designed to protect the drug from environmental conditions, mechanical damage, and natural and human hazards. At the same time, it is required to be child and leakage proof. Meeting all these requirements involve high costs in production of pharmaceutical packaging. Thus, with increasing complexity in designing pharmaceutical packaging, companies are compelled to use high-cost machinery and technology to create efficient packaging solutions.

Opportunity: Growing demand for primary pharmaceutical packaging

Primary pharmaceutical packaging are products which come in direct contact with the medicine or drug. They generally include plastic bottles, glass bottles, pre-filled syringes, pre-filled inhalers, medication tubes, blister packaging, and others. The major contributors to the growth of this segment are pre-fillable syringes and pre-fillable inhalers. Plastic bottles, blister packs, and ampoules & vials are also some of the primary pharmaceutical packaging that are growing rapidly. Advancements in biotechnology, leading to the introduction of new injectable parenteral therapies, and increased demand for high visibility unit dosage packaging for diseases such as diabetes will drive the primary packaging segment. Growth of the inhalers segment is expected to be supported by rising number of chronic asthma, allergy, and migraine patients treated with inhalation drugs. In addition, rise of advanced and diverse drug producing companies in developed economies such as the US, Japan, Canada, Germany, France, and the UK will drive the growth for primary packaging. Furthermore, India, Russia, Turkey, Mexico, Argentina, and China are expected to become some of the fastest growing markets owing to rapidly expanding pharmaceutical manufacturing capabilities and adoption of more stringent regulations intended at improving the quality and reliability of domestically produced drugs.

Challenge: Safeguarding against counterfeit products

Counterfeit or falsified pharmaceutical products has been an important concern for pharmaceutical manufacturers. In 2017, 25.0 million illicit and counterfeit drugs were seized by Interpol. Delay in approval of new drugs and their packaging due to the long product development cycles and costs are resulting in the increased availability of counterfeit drugs and fake packaging. These counterfeit products have negative effects on the human body, in terms of allergic reactions, nausea, vomiting, and others. Anti-malarials and antibiotics are among the most commonly counterfeited medical products. The WHO is constantly taking initiatives against counterfeiters by setting new standards for drug packaging. All activities related to drug serialization that evolve in different countries are backed by global initiatives managed by the WHO. The governments of developed and developing economies are implementing stringent legislations such as the US Code 2320 for tracking counterfeit products and related acts to prevent counterfeiting of pharmaceutical products. New technologies such as induction seals, near-field communication (NFC) tags, and blockchain will further boost counterfeit protection and enable proper distribution. However, counterfeiters usually crack these systems in two-three years. This issue mandates complex and expensive upgradations by pharmaceutical packaging companies on regular basis. Hence, fighting counterfeiting of products is a major challenge for pharmaceutical packaging companies.

Scope of the report

Report Metric

Details

Years Considered for the study

2017–2024

Base year

2018

Forecast period

2019–2024

Units considered

Value (USD Million)

Segments

Type, Raw Material, Drug-delivery Mode, Product type, and Region

Regions

North America, Europe, APAC,  South America  and  Middle East & Africa

Companies

Amcor plc (Australia), Gerresheimer AG (Germany), Berry Global, Inc.(US), Schott AG (Germany), AptarGroup, Inc. (US),  West Pharmaceutical Services, Inc. (US), Becton, Dickinson, and Company (US), Nipro Corporation (Japan), Catalent, Inc. (US) and WestRock Company (US), Total 25 major players covered

The research report categorizes the Pharmaceutical packaging to forecast the revenues and analyze the trends in each of the following sub-segments:

Based on type, the pharmaceutical packaging market has been segmented as follows:

  •  Plastic bottles
  •  Blister packs
  •  Labels & accessories
  •  Caps & closures
  •  Pre-fillable syringes
  •  Medical specialty bags
  •  Temperature-controlled packaging
  •  Pouches & strip packs
  •  Pre-filled inhalers
  •  Vials
  •  Ampoules
  •  Medication tubes
  •  Jars & canisters
  •  Cartridges
  •  Others (paperboard boxes, corrugated boxes, and trays)

Based on raw material, the pharmaceutical packaging market has been segmented as follows: 

  • Plastics & Polymers
  • Paper & paperboards
  • Glass
  • Metals
  • Others (rubber and steel)

Based on drug-delivery mode, the pharmaceutical packaging market has been segmented as follows:

  • Oral Drugs
  • Pulmonary
  • Transdermal
  • Injectables
  • Topical 
  • Nasal 
  • Ocular/ Ophthalmic
  • IV Drugs
  • Others (targeted drug delivery, carrier-based drug delivery, nanoparticle drug delivery, and genetic transfer)

Based on product type, the pharmaceutical packaging market has been segmented as follows:

  • Primary
  • Secondary

Based on region, the pharmaceutical packaging market has been segmented as follows:

  • North America
  • Europe
  • APAC
  • South America
  • Middle East & Africa

Key Market Players

Amcor plc (Australia), Gerresheimer AG (Germany), Berry Global, Inc. (US), Schott AG (Germany), AptarGroup, Inc. (US),  West Pharmaceutical Services, Inc. (US), Becton, Dickinson, and Company (US), Nipro Corporation (Japan), Catalent, Inc. (US) and WestRock Company (US) These companies have adopted various organic and inorganic growth strategies between 2016 and 2019 to strengthen their position in the market. New product development and investment & expansion were among the key growth strategies adopted by these leading players to establish and enhance their regional presence to meet the growing demand for pharmaceutical packaging from the emerging economies.

Recent Developments

  • In July 2019, Berry Global announced the acquisition of RPC Group PLC (UK), a major provider of rigid packaging to the wide range of end-use industries such as food, healthcare, beverage, and others. This acquisition will enable Berry to capture higher market share.
  • In June 2019, Amcor (Australia) acquired Bemis (US), a strong player in flexible packaging product manufacturing. Through this acquisition, Amcor can capitalize on the capability to serve its customer base and will strengthen its position in the competitive market.
  • In March 2019, Schott developed Everic vials for packaging of small volumes of sensitive drugs. This product benefitted to end-user with its quality fill and finish and is suitable for highly potent drugs such as biologics.
  • In March 2019, Gerresheimer announced a plan to invest for a new plant in Skopje, North Macedonia. The plant will manufacture plastic systems such as pre-fillable syringes and will start operating from the second half of 2020. This investment will reinforce the company’s strategy to expand the production network in Europe.

Critical questions the report answers:

  • What are the upcoming hot bets for the pharmaceutical packaging market?
  • How are the market dynamics for different types of pharmaceutical packaging?
  • What are the significant trends in pharmaceutical drug development industry influencing the market?
  • Who are the major manufacturers of pharmaceutical packaging?
  • What are the factors governing the pharmaceutical packaging market in each region?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 18)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
    1.3 MARKET SCOPE
           1.3.1 PHARMACEUTICAL PACKAGING MARKET SEGMENTATION
           1.3.2 REGIONS COVERED
           1.3.3 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. - 21)
    2.1 RESEARCH DATA
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Key industry insights
                    2.1.2.3 Breakdown of primary interviews
    2.2 MARKET SIZE ESTIMATION
           2.2.1 BOTTOM-UP APPROACH
           2.2.2 TOP-DOWN APPROACH
    2.3 DATA TRIANGULATION
    2.4 ASSUMPTIONS
    2.5 LIMITATIONS

3 EXECUTIVE SUMMARY (Page No. - 28)

4 PREMIUM INSIGHTS (Page No. - 32)
    4.1 ATTRACTIVE OPPORTUNITIES IN THE PHARMACEUTICAL PACKAGING MARKET
    4.2 PHARMACEUTICAL PACKAGING MARKET, BY MATERIAL
    4.3 PHARMACEUTICAL PACKAGING MARKET, BY TYPE
    4.4 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY MODE
    4.5 PHARMACEUTICAL PACKAGING MARKET, BY REGION
    4.6 NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET, BY TYPE AND COUNTRY

5 MARKET OVERVIEW (Page No. - 35)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           5.2.1 DRIVERS
                    5.2.1.1 Growing pharmaceutical industry in emerging economies
                    5.2.1.2 Growing demand for drug delivery devices and blister packaging
                    5.2.1.3 Technological advancements to contribute to the growth of pharmaceutical packaging
                    5.2.1.4 Growing health awareness and adoption of new regulatory standards
           5.2.2 RESTRAINTS
                    5.2.2.1 Increasing overall packaging costs owing to dynamic regulatory policies
                    5.2.2.2 Lack of access and awareness in emerging markets
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growing demand for primary pharmaceutical packaging
                    5.2.3.2 Expanding 3PL and other services in emerging markets
           5.2.4 CHALLENGES
                    5.2.4.1 Safeguarding against counterfeit products
    5.3 PORTER’S FIVE FORCES ANALYSIS
           5.3.1 THREAT OF NEW ENTRANTS
           5.3.2 THREAT OF SUBSTITUTES
           5.3.3 BARGAINING POWER OF BUYERS
           5.3.4 BARGAINING POWER OF SUPPLIERS
           5.3.5 INTENSITY OF COMPETITIVE RIVALRY

6 PHARMACEUTICAL PACKAGING MARKET, BY TYPE (Page No. - 44)
    6.1 INTRODUCTION
    6.2 PLASTIC BOTTLES
           6.2.1 HIGH DEMAND FOR PLASTIC BOTTLES OWING TO EASY WORKABILITY AND LIGHTWEIGHT PROPERTY
           6.2.2 STANDARD PLASTIC BOTTLES
           6.2.3 PLASTIC DISPENSING BOTTLES
           6.2.4 PLASTIC JARS
    6.3 BLISTER PACKS
           6.3.1 EFFECTIVE DRUG PROTECTION AND EASY MANUFACTURING TO DRIVE THE BLISTER PACKS MARKET
           6.3.2 COMPARTMENT PACKS
           6.3.3 WALLET PACKS
    6.4 LABELS & ACCESSORIES
           6.4.1 LABELS ARE CRUCIAL IN ENSURING PATIENT-DRUG COMMUNICATION COMPLIANCE
    6.5 CAPS & CLOSURES
           6.5.1 PLASTIC CAPS & CLOSURES ARE EXPECTED TO WITNESS HIGH GROWTH DURING THE FORECAST PERIOD
    6.6 MEDICAL SPECIALTY BAGS
           6.6.1 EASY HANDLING AND DISPOSABLE CHARACTERISTICS ARE INCREASING THE DEMAND FOR SPECIALTY BAGS
    6.7 PRE-FILLED SYRINGES
           6.7.1 HIGHER PATIENT COMPLIANCE AND INCREASING AGING POPULATION ARE DRIVING THE DEMAND FOR PRE-FILLED SYRINGES
    6.8 TEMPERATURE-CONTROLLED PACKAGING
           6.8.1 INCREASED MANUFACTURING OF SPECIALIZED DRUGS WILL FUEL THE MARKET FOR TEMPERATURE-CONTROLLED PACKAGING
    6.9 POUCHES & STRIP PACKS
           6.9.1 INCREASING DEMAND FOR STANDUP POUCHES OFFERS GROWTH PROSPECTS FOR PACKAGING MANUFACTURERS
    6.1 AMPOULES
           6.10.1 MARKET FOR AMPOULES IN DEVELOPING COUNTRIES WITNESSING A GOOD GROWTH RATE
    6.11 VIALS
           6.11.1 DEMAND FOR VIALS IN DEVELOPED COUNTRIES SLOWING DOWN
    6.12 PRE-FILLED INHALERS
           6.12.1 HIGHER DEMAND OWING TO INCREASING CASES OF PULMONARY DISEASES DRIVING THE DEMAND
           6.12.2 METERED DOSE INHALERS
           6.12.3 DRY POWDER INHALERS
    6.13 MEDICATION TUBES
           6.13.1 EASE OF USE IS DRIVING DEMAND FOR MEDICATION TUBES
           6.13.2 COMPOSITE TUBES
           6.13.3 ALL-PLASTIC TUBES
           6.13.4 COLLAPSIBLE METAL TUBES
    6.14 JARS & CANISTERS
           6.14.1 CANISTERS HELP EXTEND SHELF-LIFE OF PHARMACEUTICAL PRODUCTS
    6.15 CARTRIDGES
           6.15.1 INCREASING USE OF PRE-FILLED SYRINGES DRIVING THE DEMAND
    6.16 OTHERS

7 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL (Page No. - 60)
    7.1 INTRODUCTION
    7.2 PLASTICS & POLYMERS
           7.2.1 EXCELLENT SHATTER RESISTANT OF PLASTICS & POLYMERS BOOSTS ITS USE IN PRIMARY PACKAGING
           7.2.2 HIGH-DENSITY POLYETHYLENE
           7.2.3 POLYESTER
           7.2.4 POLYPROPYLENE
           7.2.5 LOW-DENSITY POLYETHYLENE
           7.2.6 POLYVINYL CHLORIDE
           7.2.7 CYCLIC OLEFIN COPOLYMER
           7.2.8 POLYETHYLENE TEREPHTHALATE
    7.3 PAPER & PAPERBOARDS
           7.3.1 INNOVATIONS IN SECONDARY PACKAGING TO PROPEL THE USE OF PAPER & PAPERBOARDS
    7.4 GLASS
           7.4.1 EXCELLENT CHEMICAL RESISTANCE OF GLASS TO BOOST ITS USE IN PRIMARY PACKAGING
    7.5 METALS
           7.5.1 INCREASING USE OF ALUMINIUM FOR BLISTER PACKAGING TO BOOST THE MARKET FOR METALS SEGMENT
    7.6 OTHERS

8 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY MODE (Page No. - 68)
    8.1 INTRODUCTION
    8.2 ORAL DRUG DELIVERY PACKAGING
           8.2.1 HIGH DEMAND FOR ORAL DRUG DELIVERY OWING TO EASE OF USAGE
    8.3 PULMONARY DRUG DELIVERY PACKAGING
           8.3.1 INCREASING CASES OF LUNG-RELATED DISEASES DRIVING DEMAND
    8.4 TRANSDERMAL DRUG DELIVERY PACKAGING
           8.4.1 INCREASING SMALL DOSE DRUG USAGE FUELING MARKET FOR TRANSDERMAL DRUG DELIVERY PACKAGING
    8.5 INJECTABLE PACKAGING
           8.5.1 INJECTABLES OFFER IMPROVED PATIENT COMPLIANCE
    8.6 TOPICAL DRUG DELIVERY PACKAGING
           8.6.1 PREVALENCE OF SKIN DISEASES DRIVES THE MARKET FOR TOPICAL DRUGS
    8.7 NASAL DRUG DELIVERY PACKAGING
           8.7.1 RAPID ABSORPTION AND FASTER ONSET OF ACTION PROPELLING THE USE OF NASAL DRUG SYSTEMS
    8.8 OCULAR DRUG DELIVERY PACKAGING
           8.8.1 INCREASING PREVALENCE OF EYE DISORDERS IN THE AGING POPULATION EXPECTED TO FUEL THE CONSUMPTION OF OCULAR DRUGS PACKAGING
    8.9 IV DRUGS DELIVERY PACKAGING
           8.9.1 GROWING USE DUE TO IMPROVED PATIENT COMPLIANCE AND HIGH DRUG DOSE CAPABILITY DRIVING THE DEMAND
    8.10 OTHER DRUGS DELIVERY PACKAGING

9 PHARMACEUTICAL PACKAGING MARKET, BY REGION (Page No. - 74)
    9.1 INTRODUCTION
    9.2 NORTH AMERICA
           9.2.1 US
                    9.2.1.1 The US pharmaceutical packaging market has reached new heights with rapid technological advancements
           9.2.2 CANADA
                    9.2.2.1 The country provides a competitive business environment for pharmaceutical packaging manufacturers
           9.2.3 MEXICO
                    9.2.3.1 Government initiatives in the healthcare industry are aiding high demand for pharmaceutical packaging
    9.3 EUROPE
           9.3.1 GERMANY
                    9.3.1.1 Need for advanced drug delivery systems due to the increasing aging population and non-

communicable diseases is the main reason for the growth of the pharmaceutical packaging market
           9.3.2 FRANCE
                    9.3.2.1 The demand for generic drugs in the country is growing
           9.3.3 ITALY
                    9.3.3.1 Growing exports of pharmaceuticals have a significant impact on the market
           9.3.4 UK
                    9.3.4.1 Innovations in the pharmaceutical industry are increasing the demand for pharmaceutical packaging
           9.3.5 SPAIN
                    9.3.5.1 Government initiatives in the healthcare sector will boost the demand for pharmaceutical packaging
           9.3.6 RUSSIA
                    9.3.6.1 Government initiatives for domestic production of pharmaceuticals are driving the pharmaceutical packaging market
           9.3.7 REST OF EUROPE
    9.4 APAC
           9.4.1 CHINA
                    9.4.1.1 The government is investing in R&D with a special focus on biologics and biosimilar drugs
           9.4.2 JAPAN
                    9.4.2.1 The sizeable aging population is increasing the demand for medications
           9.4.3 SOUTH KOREA
                    9.4.3.1 The country has a well-developed healthcare industry and houses major pharmaceuticals manufacturers
           9.4.4 INDIA
                    9.4.4.1 Large domestic consumption of pharmaceuticals and export of generic drugs are driving the

pharmaceutical packaging market
           9.4.5 AUSTRALIA
                    9.4.5.1 Schemes Such as Medicare and PBS are strengthening the country’s pharmaceutical industry
           9.4.6 REST OF APAC
    9.5 SOUTH AMERICA
           9.5.1 BRAZIL
                    9.5.1.1 Free and universal healthcare services supporting the growth of the pharmaceutical industry
           9.5.2 ARGENTINA
                    9.5.2.1 The population has good access to generic drugs supported by government initiatives
           9.5.3 REST OF SOUTH AMERICA
    9.6 MIDDLE EAST & AFRICA
           9.6.1 SAUDI ARABIA
                    9.6.1.1 Wider access to healthcare services is increasing the demand for pharmaceuticals
           9.6.2 SOUTH AFRICA
                    9.6.2.1 A gradual rise in generic drug usage will fuel the pharmaceutical packaging market
           9.6.3 EGYPT
                    9.6.3.1 Increasing domestic production and consumption of pharmaceuticals show potential market growth
           9.6.4 REST OF THE MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE (Page No. - 111)
     10.1 OVERVIEWS
     10.2 COMPETITIVE LEADERSHIP MAPPING, 2018
             10.2.1 VISIONARY LEADERS
             10.2.2 INNOVATORS
             10.2.3 DYNAMIC DIFFERENTIATORS
             10.2.4 EMERGING COMPANIES
     10.3 STRENGTH OF PRODUCT PORTFOLIO
     10.4 BUSINESS STRATEGY EXCELLENCE
     10.5 MARKET RANKING OF KEY PLAYERS
             10.5.1 AMCOR PLC
             10.5.2 GERRESHEIMER AG
             10.5.3 BERRY GLOBAL INC.
             10.5.4 SCHOTT AG
             10.5.5 APTARGROUP, INC.
     10.6 COMPETITIVE SITUATION & TRENDS
             10.6.1 NEW PRODUCT LAUNCH
             10.6.2 INVESTMENT & EXPANSION
             10.6.3 MERGER & ACQUISITION
             10.6.4 AGREEMENT & COLLABORATION
             10.6.5 JOINT VENTURE

11 COMPANY PROFILES (Page No. - 125)
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
     11.1 AMCOR PLC
     11.2 GERRESHEIMER AG
     11.3 BERRY GLOBAL INC.
     11.4 SCHOTT AG
     11.5 APTARGROUP, INC.
     11.6 BECTON, DICKINSON AND COMPANY
     11.7 CATALENT, INC.
     11.8 NIPRO CORPORATION
     11.9 WEST PHARMACEUTICAL SERVICES, INC.
     11.10 WESTROCK COMPANY
     11.11 OTHERS
               11.11.1 ALPLA WERKE ALWIN LEHNER GMBH & CO KG
               11.11.2 ARDAGH GROUP S. A.
               11.11.3 CONSTANTIA
               11.11.4 CCL INDUSTRIES INC.
               11.11.5 FRANK NOE EGYPT LTD
               11.11.6 GAPLAST GMBH
               11.11.7 LONZA GROUP LTD
               11.11.8 MONDI GROUP
               11.11.9 NOLATO AB
               11.11.10 ORIGIN PHARMA PACKAGING
               11.11.11 OWENS-ILLINOIS, INC.
               11.11.12 PAREKHPLAST INDIA LTD.
               11.11.13 SGD PHARMA
               11.11.14 SILGAN HOLDINGS INC.
               11.11.15 STEVANATO GROUP
               11.11.16 VETTER PHARMA INTERNATIONAL GMBH

*Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

12 APPENDIX (Page No. - 156)
     12.1 DISCUSSION GUIDE
     12.2 KNOWLEDGE STORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL
     12.3 AVAILABLE CUSTOMIZATIONS
     12.4 RELATED REPORTS
     12.5 AUTHOR DETAILS


LIST OF TABLES (71 Tables)

TABLE 1 PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2017–2024 (USD MILLION)
TABLE 2 PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017–2024 (USD MILLION)
TABLE 3 PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2017–2024 (USD MILLION)
TABLE 4 PLASTIC BOTTLES MARKET SIZE, BY REGION, 2017–2024 (USD MILLION)
TABLE 5 BLISTER PACKAGING MARKET SIZE, BY REGION, 2017–2024 (USD MILLION)
TABLE 6 LABELS & ACCESSORIES MARKET SIZE, BY REGION, 2017–2024 (USD MILLION)
TABLE 7 CAPS & CLOSURES MARKET SIZE, BY REGION, 2017–2024 (USD MILLION)
TABLE 8 MEDICAL SPECIALTY BAGS MARKET SIZE, BY REGION, 2017–2024 (USD MILLION)
TABLE 9 PRE-FILLED SYRINGES MARKET SIZE, BY REGION, 2017–2024 (USD MILLION)
TABLE 10 PRE-FILLED SYRINGES MARKET SIZE, BY REGION, 2017–2024 (MILLION UNITS)
TABLE 11 TEMPERATURE-CONTROLLED PACKAGING MARKET SIZE, BY REGION, 2017–2024 (USD MILLION)
TABLE 12 POUCHES & STRIP PACKS MARKET SIZE, BY REGION, 2017–2024 (USD MILLION)
TABLE 13 AMPOULES MARKET SIZE, BY REGION, 2017–2024 (USD MILLION)
TABLE 14 VIALS MARKET SIZE, BY REGION, 2017–2024 (USD MILLION)
TABLE 15 VIALS MARKET SIZE, BY REGION, 2017–2024 (MILLION UNITS)
TABLE 16 PRE-FILLED INHALERS MARKET SIZE, BY REGION, 2017–2024 (USD MILLION)
TABLE 17 MEDICATION TUBES MARKET SIZE, BY REGION, 2017–2024 (USD MILLION)
TABLE 18 JARS & CANISTERS MARKET SIZE, BY REGION, 2017–2024 (USD MILLION)
TABLE 19 CARTRIDGES MARKET SIZE, BY REGION, 2017–2024 (USD MILLION)
TABLE 20 OTHERS MARKET SIZE, BY REGION, 2017–2024 (USD MILLION)
TABLE 21 BASIC PACKAGING RAW MATERIAL USED IN PHARMACEUTICAL PACKAGING
TABLE 22 PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2017–2024 (USD MILLION)-*
TABLE 23 PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2017–2024 (MILLION TONS)-
TABLE 24 PHARMACEUTICAL PACKAGING MARKET SIZE (RAW MATERIAL), BY REGION, 2017–2024 (USD MILLION)
TABLE 25 TYPE OF GLASS USED FOR DIFFERENT PACKAGING
TABLE 26 PHARMACEUTICAL PACKAGING MARKET (DRUG DELIVERY MODE), BY REGION, 2017–2024 (USD MILLION)
TABLE 27 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY MODE, 2017–2024 (USD MILLION)
TABLE 28 PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2017–2024 (USD MILLION)
TABLE 29 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 30 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017–2024 (USD MILLION)
TABLE 31 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2017–2024 (USD MILLION)
TABLE 32 US: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017–2024 (USD MILLION)
TABLE 33 CANADA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017–2024 (USD MILLION)
TABLE 34 MEXICO: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017–2024 (USD MILLION)
TABLE 35 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 36 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017–2024 (USD MILLION)
TABLE 37 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2017–2024 (USD MILLION)
TABLE 38 GERMANY: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017–2024 (USD MILLION)
TABLE 39 FRANCE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017–2024 (USD MILLION)
TABLE 40 ITALY: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017–2024 (USD MILLION)
TABLE 41 UK: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017–2024 (USD MILLION)
TABLE 42 SPAIN: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017–2024 (USD MILLION)
TABLE 43 RUSSIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017–2024 (USD MILLION)
TABLE 44 REST OF EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017–2024 (USD MILLION)
TABLE 45 APAC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 46 APAC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017–2024 (USD MILLION)
TABLE 47 APAC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2017–2024 (USD MILLION)
TABLE 48 CHINA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017–2024 (USD MILLION)
TABLE 49 JAPAN: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017–2024 (USD MILLION)
TABLE 50 SOUTH KOREA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017–2024 (USD MILLION)
TABLE 51 INDIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017–2024 (USD MILLION)
TABLE 52 AUSTRALIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017–2024 (USD MILLION)
TABLE 53 REST OF APAC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017–2024 (USD MILLION)
TABLE 54 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 55 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017–2024 (USD MILLION)
TABLE 56 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2017–2024 (USD MILLION)
TABLE 57 BRAZIL: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017–2024 (USD MILLION)
TABLE 58 ARGENTINA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017–2024 (USD MILLION)
TABLE 59 REST OF SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017–2024 (USD MILLION)
TABLE 60 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 61 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017–2024 (USD MILLION)
TABLE 62 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2017–2024 (USD MILLION)
TABLE 63 SAUDI ARABIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017–2024 (USD MILLION)
TABLE 64 SOUTH AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017–2024 (USD THOUSAND)
TABLE 65 EGYPT: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017–2024 (USD THOUSAND)
TABLE 66 REST OF THE MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017–2024 (USD THOUSAND)
TABLE 67 NEW PRODUCT LAUNCH (2016–2019)
TABLE 68 INVESTMENT & EXPANSION (2016–2019)
TABLE 69 MERGER & ACQUISITION (2016–2019)
TABLE 70 AGREEMENT & COLLABORATION (2016–2019)
TABLE 71 JOINT VENTURE (2016–2019)
 
 
LIST OF FIGURES (40 Figures)
 
FIGURE 1 PHARMACEUTICAL PACKAGING MARKET: RESEARCH DESIGN
FIGURE 2 PHARMACEUTICAL PACKAGING MARKET: DATA TRIANGULATION
FIGURE 3 PLASTICS & POLYMERS WAS THE LARGEST RAW MATERIAL SEGMENT FOR PHARMACEUTICAL PACKAGING IN 2018
FIGURE 4 PLASTIC BOTTLES TO BE LARGEST TYPE OF PHARMACEUTICAL PACKAGING
FIGURE 5 ORAL DRUG DELIVERY TO BE LARGEST DRUG DELIVERY MODE IN PHARMACEUTICAL PACKAGING
FIGURE 6 APAC TO BE THE FASTEST-GROWING PHARMACEUTICAL PACKAGING MARKET
FIGURE 7 GROWTH IN DEMAND FOR MEDICINES AND RELATED PACKAGING IN PHARMERGING ECONOMIES TO DRIVE THE MARKET
FIGURE 8 PLASTICS & POLYMERS TO BE THE LARGEST RAW MATERIAL SEGMENT IN OVERALL PHARMACEUTICAL PACKAGING
FIGURE 9 PLASTIC BOTTLES TO BE THE LARGEST PACKAGING TYPE IN OVERALL PACKAGING MARKET
FIGURE 10 ORAL DRUG DELIVERY TO BE THE LARGEST SEGMENT IN OVERALL PACKAGING MARKET
FIGURE 11 INDIA TO BE THE FASTEST-GROWING MARKET IN APAC
FIGURE 12 PLASTIC BOTTLES ACCOUNTED FOR THE LARGEST MARKET SHARE
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN PHARMACEUTICAL PACKAGING MARKET
FIGURE 14 PORTER’S FIVE FORCES ANALYSIS: PHARMACEUTICAL PACKAGING MARKET
FIGURE 15 PLASTIC BOTTLES ACCOUNT FOR LARGEST SHARE OF OVERALL PHARMACEUTICAL PACKAGING MARKET
FIGURE 16 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL
FIGURE 17 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY MODE (2019–2024)
FIGURE 18 PHARMACEUTICAL PACKAGING MARKET IN INDIA WILL REGISTER THE HIGHEST CAGR
FIGURE 19 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SNAPSHOT
FIGURE 20 EUROPE: PHARMACEUTICAL PACKAGING MARKET SNAPSHOT
FIGURE 21 APAC: PHARMACEUTICAL PACKAGING MARKET SNAPSHOT
FIGURE 22 COMPANIES ADOPTED EXPANSION, NEW PRODUCT LAUNCH, AND ACQUISITION AS KEY STRATEGIES BETWEEN 2016 AND 2019
FIGURE 23 PHARMACEUTICAL PACKAGING MARKET: COMPETITIVE LEADERSHIP MAPPING, 2018
FIGURE 24 PRODUCT PORTFOLIO ANALYSIS OF TOP PLAYERS IN PHARMACEUTICAL PACKAGING MARKET
FIGURE 25 BUSINESS STRATEGY EXCELLENCE OF TOP PLAYERS IN PHARMACEUTICAL PACKAGING MARKET
FIGURE 26 AMCOR: COMPANY SNAPSHOT
FIGURE 27 AMCOR : SWOT ANALYSIS
FIGURE 28 GERRESHEIMER AG: COMPANY SNAPSHOT
FIGURE 29 GERRESHEIMER: SWOT ANALYSIS
FIGURE 30 BERRY GLOBAL: COMPANY SNAPSHOT
FIGURE 31 BERRY GLOBAL: SWOT ANALYSIS
FIGURE 32 SCHOTT: COMPANY SNAPSHOT
FIGURE 33 SCHOTT: SWOT ANALYSIS
FIGURE 34 APTARGROUP: COMPANY SNAPSHOT
FIGURE 35 APTARGROUP: SWOT ANALYSIS
FIGURE 36 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
FIGURE 37 CATALENT: COMPANY SNAPSHOT
FIGURE 38 NIPRO CORPORATION: COMPANY SNAPSHOT
FIGURE 39 WEST PHARMACEUTICAL SERVICES: COMPANY SNAPSHOT
FIGURE 40 WESTROCK COMPANY: COMPANY SNAPSHOT

The study involved four major activities in estimating the current market size for pharmaceutical packaging. The exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, the market breakdown and data triangulation methodologies were used to estimate the market size of segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as Hoovers, Bloomberg, and BusinessWeek were referred to for identifying and collecting information for this study. These secondary sources included annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold standard & silver standard websites, packaging related organizations, regulatory bodies, and databases.

Primary Research 

The pharmaceutical packaging market comprises several stakeholders such as raw material suppliers, distributors of pharmaceutical packaging, raw material associations, polymer and resin associations, pharmaceuticals and pharmaceutical packaging related associations, end-users of pharmaceutical packaging, and regulatory organizations in the supply chain. The demand side of this market consists of drug developers and medical institutions, whereas the supply side consists of packaging material manufacturers. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. Following is the breakdown of primary respondents

Pharmaceutical Packaging Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the pharmaceutical packaging market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets were identified through extensive secondary research.
  • The industry’s supply chain and market size, in terms of value, were determined through primary and secondary research.
  • All the percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources.

Data Triangulation

After arriving at the overall market size-using the estimation processes as explained above-the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the pharmaceutical packaging.

Objectives of the Study:

  • To define, describe, and forecast the size of the pharmaceutical packaging market in terms of value
  • To provide detailed information about the key factors (drivers, restraints, challenges, and opportunities) influencing the market
  • To analyze the market segmentation and forecast the pharmaceutical packaging market size based on type, raw material, and drug delivery
  • To forecast the market size with respect to four regions, namely, Asia Pacific (APAC), Europe, North America, the Middle East & Africa, and South America, along with their key countries
  • To strategically analyze micromarkets1 with respect to their individual growth trends, growth prospects, and their contribution to the overall market
  • To analyze the opportunities in the market for stakeholders and provide a competitive landscape for the market leaders
  • To analyze competitive developments such as new product development, investment & expansion, and merger & acquisition in the market
  • To strategically profile the key players and comprehensively analyze their market ranking and core competencies2

Notes: Micromarkets1 are defined as subsegments of the pharmaceutical packaging market included in the report.

Core competencies2 of the companies are determined in terms of their key developments, SWOT analysis, and strategies adopted to sustain their position in the market.

Available Customizations:

With the given market data, MarketsandMarkets offers customizations according to the company’s specific needs. The following customization options are available for the report:

Regional Analysis:

  • A country-level analysis of the pharmaceutical packaging market is provided based on the type of pharmaceutical packaging.

Company Information:

  • Detailed analysis and profiles of additional market players.
Report Code
CH 3482
Published ON
Jul, 2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Pharmaceutical Packaging Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home